Single academic center experience of unrestricted β-d-glucan implementation

Maria Valeria Fabre, Theodore Markou, Kathryn Demallie, Seema Mehta, Shmuel Shoham, Pranita Tamma, Sean Xiang Zhang, Sara Cosgrove

Research output: Contribution to journalArticle


We investigated serum β-d-glucan (BDG) testing among non-neutropenic adult inpatients at an academic center where the test is unrestricted. BDG orders were inappropriate in 49% of cases due to absence of predisposing host factors or clinical picture consistent with fungal infection. Providers' knowledge about BDG was insufficient.

Original languageEnglish (US)
Article numberofy195
JournalOpen Forum Infectious Diseases
Issue number9
Publication statusPublished - Sep 1 2018



  • Fungal infection
  • Implementation.
  • β-D-glucan

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology

Cite this